HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
WEDNESDAY, Aug. 8 (HealthDay News) -- Comprehensive behavioral intervention for tics (CBIT) is effective for treating adults with Tourette syndrome, according to a study published in the August issue of the Archives of General Psychiatry.
To test the efficacy of CBIT, Sabine Wilhelm, Ph.D., from Massachusetts General Hospital/Harvard Medical School in Boston, and colleagues conducted a randomized, controlled trial, in which 122 patients (78 males aged 16 to 69 years) with Tourette syndrome or chronic tic disorder were assigned to eight sessions of CBIT or eight sessions of supportive treatment delivered over 10 weeks. Three monthly booster sessions were given to participants who showed a positive response.
The researchers found that, from baseline to end point, CBIT was associated with a significantly greater decrease on the Yale Global Tic Severity Scale compared to the control treatment (P < 0.001; effect size, 0.57). Using the Clinical Global Impression-Improvement scale, 38.1 percent of the CBIT participants were rated as "much improved" or "very much improved," compared with 6.8 percent in the control group (P < 0.0001). There was no difference in attrition between the groups (13.9 percent). For those subjects available for assessment at six months post-treatment, behavior therapy showed continued benefit.
"Comprehensive behavior therapy is a safe and effective intervention for adults with Tourette syndrome," write the authors.
Several authors disclosed financial ties to pharmaceutical companies.
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at firstname.lastname@example.org with any questions.
Updated on June 04, 2022